Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
ACTIVE NOT RECRUITING
NCT06121232
NA
Exploring the Benefit of Neuromodulation in Treating Chemo-induced Peripheral Neuropathy Using Peripheral Neuropathy Markers (Meissner's Corpuscles and Epidermal Nerve Fiber Density) and Sensory Testing (Quantitative Sensory and Gait Testing): A Single Center Feasibility Study
Sponsor: M.D. Anderson Cancer Center
View on ClinicalTrials.gov
Summary
To learn if a process called neuromodulation can help to improve pain due to CIP
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
24
Start Date
2023-11-02
Completion Date
2026-04-01
Last Updated
2025-11-17
Healthy Volunteers
No
Conditions
Interventions
DEVICE
Abbott® DRG / Abbott®/Medtronic® SCS
Participants will receive 1 of 2 neuromodulation procedures based on if participants are expected to have an MRI in the near future.
OTHER
Control Group
Participants will not receive any intervention
Locations (1)
M D Anderson Cancer Center
Houston, Texas, United States